Abstract : Dietary L-glutamate (Glu), an amino acid abundant in many foodstuffs in a free form, is able to modulate physiological functions in the stomach, including secretion and motility. Recently, specific receptors for Glu were identified in the apical membrane of chief cells in the lower region of fundic glands and in the somatostatin-secreting D-cell fraction of the gastric mucosa. This Glu-sensing system in the stomach is linked to activation of the vagal afferents. Among 20 kinds of amino acid, luminal Glu alone activated the vagal afferents in the stomach through a paracrine cascade led by nitric oxide and followed by serotonin (5-HT). In dogs with Pavlov pouches, found that supplementation of an amino acid-rich diet lacking Glu with monosodium Glu (MSG) enhanced the secretion of acid, pepsinogen, and fluid. However, MSG did not affect these secretions induced by a carbohydrate-rich diet and it had no effect on basal secretion when MSG was applied alone without the diet. Enhancement of gastric secretion by MSG was abolished by blockage of the gastric afferents using intra-gastric applied lidocaine. This effect of MSG was due in part to stimulation of 5-HT3 receptors in the gastric mucosa. J. Med. Invest. 56 Suppl. : 218-223, December, 2009
INTRODUCTION
The gastric mucosa recognizes a variety of chemical characteristics of food from simple, such as osmotic pressure and pH, to complex, such as molecules of macronutrients. These chemical characteristics of a meal signal quality as well as quantity. This information alters gastric secretomotor function by activating specific nervous and endocrine pathways and related mechanisms at the very beginning of digestive process (1, 2) . Among other nutrients, amino acids and short hydrophobic peptides are known as the most active stimuli inducing gastrin release and acid secretion in the stomach (3, 4) . The origin of free amino acids and short peptides in the gastric lumen is straightforward. Ingested dietary protein and peptides are cleaved by activated pepsin preferentially on the COOH-terminal sides of aromatic amino acids including L-Phe, L-Trp and L-Tyr (5) . Thus, at the beginning of protein digestion some short peptides and amino acids are released before exiting the stomach. The only amino acid which is regularly ingested in a free form is glutaminic acid or its ionic form glutamate, well recognized for its characteristic umami taste.
MINI-REVIEW

Dietary monosodium glutamate enhances gastric secretion
FREE GLUTAMATE IN GASTRIC LUMEN
L-Glutamate (Glu) in a free form is found at marked concentrations both in animal and plant foodstuffs such as green tea, seaweed, mushrooms, potato, Chinese cabbage, soybean, sardines, shrimps, and milk (6) . High concentrations of Glu are found in ripe tomatoes (140 mg/100 g) and in Parmesan cheese (1200 mg/100 g). As a food additive, Glu is generally used as a sodium salt (monosodium glutamate, MSG). Average consumption for Europeans is 0.3-0.5 g/day individually ; in Asian countries the intake of added Glu is estimated to 1.2-1.7 g/day (7) . An important potential application of free dietary Glu is to use it in supplements of hospital meals and diets for enteral nutrition. Glu is a major oxidative fuel and an important substrate for the synthesis of the other amino acids, glutathione, and protein in the intestine (8, 9) and is often applied to augment gut function. Addition of 3 g of Glu to daily hospital meals of patients with chronic atrophic gastritis for 24 days improved appetite, gastric acid secretion and secretion of gastrin (10) . In parallel, this treatment reduced dyspepsia, and lipid peroxidation and caused an increase of body mass (11) . Enteral Glu brought a survival advantage to hematological and oncological patients (12) . In elderly patients, MSG supplementation of food caused an increase of food intake and improved nutritional status (13) . Furthermore, moderate increase of luminal Glu may offer a therapeutic approach to stimulate gastroduodenal contractile activity and to reduce feeding intolerance in premature infants (14, 15) .
GASTRIC MUCOSA SENSING OF GLUTA-MATE
There is little doubt that the gastrointestinal (GI) mucosa is the main site for regulatory action of enteral Glu, because under normal circumstances of digestion, almost all ingested Glu is extensively metabolized in the mucosal cells and does not appear in the portal circulation (8) . Several sites of interaction of dietary amino acids are described at the apical membranes of gastric mucosal cell, including calcium sensing receptors (CaSRs) (1, 4) , metabotropic glutamate receptors type 1 (mGluR1) (16) , T1R1/ T1R3 peptides (17) , and amino acid transporters (18) . CaSRs are expressed in gastric acid-secreting parietal cells and pepsinogen-secreting chief cells (19, 20) , as well as in surface mucus-secreting cells (21) and gastrin-secreting G-cells in the antrum (22) . These receptors activated by divalent cations are also sensitized by several kinds of amino acids, i.e. aromatic, polar and acidic ones, but aromatic amino acids are the most potent among them (1) . A specific taste receptor for Glu (mGluR1) was initially revealed immunohistochemically at the apical membrane of chief cells in the lower region of the fundic glands in the rat stomach (16) . Quite recently, Gi-protein coupling mGluR subtypes were also identified in the somatostatin-secreting D-cell fraction of the gastric mucosa (23) . The heterodimer T1r1/ T1r3 is known as an umami taste receptor in the taste buds on the surface of the tongue. These dimer components were identified by PCR in the antral stomach tissues of mice (17) . However, the precise localization of the T1r1 and T1r3 heterodimer in stomach mucosa is not yet been reported. Finally, the excitatory amino acid transporter 1 (GLAST) has been labeled along the luminal surface both mucus neck cells and parietal cell of the mouse stomach (18) .
DIETARY GLUTAMATE AND DIGESTIVE FUNCTIONS
There is substantial evidence that dietary glutamate, identified by gustatory and gut receptors, modulates physiological functions in the GI tract. Oral uptake of MSG stimulates cephalic phase exocrine secretions of saliva, bile and pancreatic juice (24) (25) (26) , in parallel with secretion of insulin (27) . In the 1990s, a role of dietary Glu in control of the gastric secretion was first investigated in series of studies in dogs. Ingestion of 2.8 g of MSG elevated and prolonged secretion of gastric juice induced by either meaty food or injection of pentagastrin (28) . However, aqueous MSG solution did not affect these basal levels nor secretion caused by sham feeding in dogs (29) . Further, in healthy human volunteers, enrichment of liquid diets with 0.5% MSG (w/v) enhanced the gastric empting rate. However, intubation of aqueous MSG solution alone did not affect stomach motility as compared to water. Physiological functions of MSG in the stomach are varied depending on the co-existing macronutrients, i.e. protein, carbohydrate, fat and so on. For example, gastric empting rate of liquid diet is enhanced when MSG is co-applied with protein diet but does not in the case of protein free one. This permissive effect is coupled with recognition of individual macronutrient Glu-sensing systems in the stomach are linked to activation of the vagal afferents that transmit food signals to the brain. Short latency impulse discharges of both afferent and efferent fibers of the gastric branches of the vagus nerve were stimulated specifically by luminally applied Glu but not other natural amino-acids (2, 31). In contrast, hepatic afferents respond to all amino acids delivered into the portal vein (32) . Luminal Glu activates the vagal afferents in the gastric submucosa through the paracrine cascade, led by nitric oxide and followed by serotonin (5-HT), which in turn interacts with 5-HT3 receptors on afferent fibers (2, 33).
LUMINAL MSG AND GASTRIC SECRE-TION
As described above, luminally applied Glu modulates gastric functions via local mechanisms, by interacting directly with secretory cells in the gastric glands, or through neuroendocrine pathways. We have recently studied the role of enteral MSG in vago-vagal reflex control of gastric secretion. In this research we used the dog model with a surgically split stomach, known as a small gastric pouch, as originally described by Pavlov (34). The small gastric pouch was prepared from tissues of the fundus and the upper corpus preserving vagal branches. It was fully separated from the main stomach, so that solutions applied to the main stomach did not interact with mucosa of the pouch. Aqueous MSG solutions intubated through a fistula directly into the main stomach at concentrations of 10-100 mM did not affect basal secretion from the small Pavlov gastric pouch. In contrast, a small amount (20 mL) of liquid diet (Elental), containing 17 amino acids as the protein source (excluding Glu), or a carbohydrate -rich diet (based on decstrin) without amino acids (both manufactured by Ajinomoto Co., Inc, Tokyo, Japan) stimulated moderate acid and fluid output from the pouch. Supplementation of Elental with 10-100 mM MSG (equimolar NaCl used as control) enhanced secretion of acid and fluid in a concentration-dependent fashion. Furthermore, addition of MSG induced pepsinogen production in the pouch, which did not occur when the Elental liquid diet was infused alone. However, MSG had no enhancing effect on the secretory response to the carbohydrate-rich diet (Fig. 1) . The stimulative effect of MSG in the Elental liquid diet was totally Fig. 1 Supplementation with 100 mM monosodium L -glutamate (MSG) enhanced gastric secretion induced by a high-caloric amino acid-rich diet, but it did not affect secretion induced by a carbohydrate -rich amino acid-free diet in Pavlov pouch dogs. A) Secretion of acid, pepsinogen and fluid in the small gastric pouch stimulated with an amino acid-rich diet (see details in the text). B) Secretion in the small gastric pouch induced by a carbohydrate -rich, amino acid-free diet. Both diets were infused through a fistula into the main stomach ; secretions were measured in the washes from the Pavlov pouch. Data are expressed as means!SEM. Solutions were intubated into the main stomach after a 45 -min stabilization period ; bolus infusions are marked with arrows. Paired comparisons were made with Student's t test ; * : p!0.05, ** : p!0.01 ; n= 9 in each group. suppressed after intra-gastric infusion of a local anesthetic, lidocaine (5%), which blocked submucosal afferent responses. Recently it has been shown that antagonism of 5-HT3 receptors with granisetron selectively attenuates Glu-specific impulse discharge in gastric branches of the vagus nerve associated with stimulation of mucosal mGluR1 (2). In our study, granisetron (20 μg/kg, i.v.) did not affect basal secretions from the Pavlov gastric pouch but it did attenuate increases in secretion when MSG was co-applied with Elental. Blockage of 5-HT3 receptors totally abolished the MSG-induced increase of pepsinogen secretion and partially reduced the enhancement of acid and fluid output, indicating that the effect of dietary MSG on gastric secretion is partially mediated by 5-HT3 receptors.
CONCLUSIONS
The regulatory role of umami substances in the process of digestion is not restricted to cephalic phase secretion of digestive juices and insulin which depend upon excitation of taste receptors in the oral cavity. Being the only amino-acid regularly ingested in a free form, Glu in the stomach induces physiological effects. It directly interacts with receptors on both exocrine and endocrine cell in the gastric mucosa, for example chief cells and probably also D-cells, and it stimulates nervous pathways. At doses not exceeding its typical concentrations in food, itragastrically applied Glu activates vagal afferent fibers in the stomach through production and release of nitric oxide and consequently serotonin in mucosal cells. We have shown that stimulation of the gastric afferent response by direct infusion of Glu into the stomach enhances gastric phase secretion, especially secretion of pepsinogen ; and that this effect partially depends on activation of 5-HT3 receptors. In several experimental models it was demonstrated that aqueous solutions of MSG do not affect secretion or motility in the stomach. Instead, MSG becomes a moderate activator of gastric functions when it is co-applied with other nutrients. Importantly, Glu selectively interacts with nutrients, enhancing the effects of protein-or amino acid-rich diets but does not have this effect with a proteinfree carbohydrate diet. New data concerning the expression of Glu receptors on D-cells allow us to speculate that nervous system effect induced by dietary MSG on gastric secretion is amplified by simultaneous MSG-induced reduction of somatostatin release (23) . Finally, the success of the enteral feeding of patients may depend on the secretory state of the stomach (35). Our studies in combination with others previously published show that free Glu supplementation of elementary liquid diets should improve gastric secretory capacity and enhance motility. MSG supplement of liquid diets should be considered for patients with GI complications. 
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